非小细胞肺癌三维适形放疗放射性肺损伤临床及剂量学因素分析

被引:34
作者
王静
王平
庞青松
王伟
王军
袁智勇
机构
[1] 天津医科大学附属肿瘤医院放疗科天津市肺癌诊治中心天津市“肿瘤防治”重点实验室
基金
天津市自然科学基金;
关键词
肺肿瘤/放射疗法; 放射疗法,三维适形; 放射性肺损伤; 因素分析;
D O I
暂无
中图分类号
R686 [筋腱、韧带、滑囊疾病及损伤];
学科分类号
100220 [骨科学];
摘要
目的探讨非小细胞肺癌(NSCLC)根治性三维适形放疗(3DCRT)后放射性肺损伤发生因素。方法搜集86例接受根治性3DCRT[处方剂量≥60~66 Gy,1.8~2.0 Gy/(次·d),5 d/周]的NSCLC患者资料,对性别、年龄、吸烟史、心脏病史、肺功能、发病部位、临床分期、病理诊断、是否合并化疗等临床因素以及放疗剂量、射野数量、平均肺受量(MLD)、正常肺体积剂量(V5~V65间隔5 Gy)等剂量学因素与放射性肺损伤之间的关系进行回顾性分析。采用CTC 3.0标准对放射性肺损伤进行分级,单因素及多因素分析筛选预测因素。结果中位随访期12个月(1~36个月),12例发生≥3级放射性肺损伤。单因素分析V5~V35、MLD等因素与放射性肺损伤有关,而与全部临床因素、放疗剂量、照射野数、V40~V65等无关。筛选单因素分析中有统计学意义的因素进行Logistic回归分析,结果仅V5是放射性肺损伤发生的独立预后因素(x2=5.15,P=0.023)。V5≤45%组放射性肺损伤发病率为2%,V5>45%组为26%(x2=10.24,P=0.001)。结论受照体积可能比受照剂量对放射性肺损伤发生的影响更大。众多剂量学因素与放射性肺损伤发生相关,其中V5是独立预后因素。
引用
收藏
相关论文
共 10 条
[1]
三维适形放疗对Ⅲ期非小细胞肺癌肺功能影响的初步观察 [J].
蔡峰 ;
李光 ;
赵玉霞 ;
党军 ;
姚雷 ;
吴春丽 .
中华放射肿瘤学杂志, 2006, (06) :440-443
[2]
Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates [J].
Schallenkamp, John M. ;
Miller, Robert C. ;
Brinkmann, Debra H. ;
Foote, Tyler ;
Garces, Yolanda I. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (02) :410-416
[3]
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).[J].Shulian Wang;Zhongxing Liao;Xiong Wei;Helen H. Liu;Susan L. Tucker;Chao-su Hu;Rodhe Mohan;James D. Cox;Ritsuko Komaki.International Journal of Radiation Oncology; Biology; Physics.2006, 5
[4]
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery [J].
Wang, SL ;
Liao, ZX ;
Vaporciyan, AA ;
Tucker, SL ;
Liu, H ;
Wei, X ;
Swisher, S ;
Ajani, JA ;
Cox, JD ;
Komaki, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (03) :692-699
[5]
Regional differences in lung radiosensitivity after radiotherapy for non–small-cell lung cancer.[J].Yvette Seppenwoolde;Katrien De Jaeger;Liesbeth J. Boersma;José S.A. Belderbos;Joos V. Lebesque.International Journal of Radiation Oncology; Biology; Physics.2004, 3
[6]
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer [J].
Tsujino, K ;
Hirota, S ;
Endo, M ;
Obayashi, K ;
Kotani, Y ;
Satouchi, M ;
Kado, T ;
Takada, Y .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (01) :110-115
[7]
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy [J].
Yorke, ED ;
Jackson, A ;
Rosenzweig, KE ;
Merrick, SA ;
Gabrys, D ;
Venkatraman, ES ;
Burman, CM ;
Leibel, SA ;
Ling, CC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02) :329-339
[8]
Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer [J].
Hernando, ML ;
Marks, LB ;
Bentel, GC ;
Zhou, SM ;
Hollis, D ;
Das, SK ;
Fan, M ;
Munley, MT ;
Shafman, TD ;
Anscher, MS ;
Lind, PA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03) :650-659
[9]
Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).[J].Mary V Graham;James A Purdy;Bahman Emami;William Harms;Walter Bosch;Mary Ann Lockett;Carlos A Perez.International Journal of Radiation Oncology; Biology; Physics.1999, 2
[10]
肿瘤放射治疗学.[M].陈东福等著;殷蔚伯;谷铣之主编;.中国协和医科大学出版社.2002,